Literature DB >> 24328079

Neurosteroid analogues. 18. Structure-activity studies of ent-steroid potentiators of γ-aminobutyric acid type A receptors and comparison of their activities with those of alphaxalone and allopregnanolone.

Mingxing Qian1, Kathiresan Krishnan, Eva Kudova, Ping Li, Brad D Manion, Amanda Taylor, George Elias, Gustav Akk, Alex S Evers, Charles F Zorumski, Steven Mennerick, Douglas F Covey.   

Abstract

A model of the alignment of neurosteroids and ent-neuron class="Chemical">steroids at the same binding site on γ-aminobutyric acid type A (GABAA) receptors was evaluated for its ability to identify the structural features in ent-neurosteroids that enhance their activity as positive allosteric modulators of this receptor. Structural features that were identified included: (1) a ketone group at position C-16, (2) an axial 4α-OMe group, and (3) a C-18 methyl group. Two ent-steroids were identified that were more potent than the anesthetic steroid alphaxalone in their threshold for and duration of loss of the righting reflex in mice. In tadpoles, loss of righting reflex for these two ent-steroids occurs with EC50 values similar to those found for allopregnanolone. The results indicate that ent-steroids have considerable potential to be developed as anesthetic agents and as drugs to treat brain disorders that are ameliorated by positive allosteric modulators of GABAA receptor function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24328079      PMCID: PMC3951241          DOI: 10.1021/jm401577c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  43 in total

1.  The enantiomer of progesterone acts as a molecular neuroprotectant after traumatic brain injury.

Authors:  Jacob W VanLandingham; Sarah M Cutler; Sharad Virmani; Stuart W Hoffman; Douglas F Covey; Kathiresan Krishnan; Stephen R Hammes; Michelle Jamnongjit; Donald G Stein
Journal:  Neuropharmacology       Date:  2006-08-22       Impact factor: 5.250

2.  Neurosteroid analogues. 15. A comparative study of the anesthetic and GABAergic actions of alphaxalone, Δ16-alphaxalone and their corresponding 17-carbonitrile analogues.

Authors:  Achintya K Bandyopadhyaya; Brad D Manion; Ann Benz; Amanda Taylor; Nigam P Rath; Alex S Evers; Charles F Zorumski; Steven Mennerick; Douglas F Covey
Journal:  Bioorg Med Chem Lett       Date:  2010-09-15       Impact factor: 2.823

3.  Nor steroids. X. Synthesis of A-nor steroids via the Dieckmann condensation.

Authors:  H R Nace; A H Smith
Journal:  J Org Chem       Date:  1973-05-18       Impact factor: 4.354

4.  Neurosteroid analogues. 17. Inverted binding orientations of androsterone enantiomers at the steroid potentiation site on γ-aminobutyric acid type A receptors.

Authors:  Kathiresan Krishnan; Brad D Manion; Amanda Taylor; John Bracamontes; Joseph H Steinbach; David E Reichert; Alex S Evers; Charles F Zorumski; Steven Mennerick; Douglas F Covey
Journal:  J Med Chem       Date:  2012-01-18       Impact factor: 7.446

5.  Neurosteroid analogues. 4. The effect of methyl substitution at the C-5 and C-10 positions of neurosteroids on electrophysiological activity at GABAA receptors.

Authors:  M Han; C F Zorumski; D F Covey
Journal:  J Med Chem       Date:  1996-10-11       Impact factor: 7.446

6.  Enantioselectivity of pregnanolone-induced gamma-aminobutyric acid(A) receptor modulation and anesthesia.

Authors:  D F Covey; D Nathan; M Kalkbrenner; K R Nilsson; Y Hu; C F Zorumski; A S Evers
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

7.  A synthetic 18-norsteroid distinguishes between two neuroactive steroid binding sites on GABAA receptors.

Authors:  Alex S Evers; Zi-Wei Chen; Brad D Manion; Mingcheng Han; Xin Jiang; Ramin Darbandi-Tonkabon; Tristan Kable; John Bracamontes; Charles F Zorumski; Steven Mennerick; Joe Henry Steinbach; Douglas F Covey
Journal:  J Pharmacol Exp Ther       Date:  2010-02-02       Impact factor: 4.030

8.  Synthesis, characterization, and receptor interaction profiles of enantiomeric bile acids.

Authors:  Bryson W Katona; Carolyn L Cummins; Andrew D Ferguson; Tingting Li; Daniel R Schmidt; David J Mangelsdorf; Douglas F Covey
Journal:  J Med Chem       Date:  2007-10-27       Impact factor: 7.446

9.  The influence of neuroactive steroid lipophilicity on GABAA receptor modulation: evidence for a low-affinity interaction.

Authors:  Mariangela Chisari; Lawrence N Eisenman; Kathiresan Krishnan; Achintya K Bandyopadhyaya; Cunde Wang; Amanda Taylor; Ann Benz; Douglas F Covey; Charles F Zorumski; Steven Mennerick
Journal:  J Neurophysiol       Date:  2009-06-24       Impact factor: 2.714

10.  Natural and enantiomeric etiocholanolone interact with distinct sites on the rat alpha1beta2gamma2L GABAA receptor.

Authors:  Ping Li; John Bracamontes; Bryson W Katona; Douglas F Covey; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2007-03-06       Impact factor: 4.436

View more
  10 in total

Review 1.  Clinical Potential of Neurosteroids for CNS Disorders.

Authors:  Doodipala Samba Reddy; William A Estes
Journal:  Trends Pharmacol Sci       Date:  2016-05-05       Impact factor: 14.819

2.  Neurosteroid Structure-Activity Relationships for Functional Activation of Extrasynaptic δGABA(A) Receptors.

Authors:  Chase Matthew Carver; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2016-02-08       Impact factor: 4.030

Review 3.  Neurosteroids for the potential protection of humans against organophosphate toxicity.

Authors:  Doodipala Samba Reddy
Journal:  Ann N Y Acad Sci       Date:  2016-07-23       Impact factor: 5.691

4.  3β-Methyl-Neurosteroid Analogs Are Preferential Positive Allosteric Modulators and Direct Activators of Extrasynaptic δ-Subunit γ-Aminobutyric Acid Type A Receptors in the Hippocampus Dentate Gyrus Subfield.

Authors:  Shu-Hui Chuang; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2018-03-30       Impact factor: 4.030

5.  A clickable neurosteroid photolabel reveals selective Golgi compartmentalization with preferential impact on proximal inhibition.

Authors:  Xiaoping Jiang; Hong-Jin Shu; Kathiresan Krishnan; Mingxing Qian; Amanda A Taylor; Douglas F Covey; Charles F Zorumski; Steven Mennerick
Journal:  Neuropharmacology       Date:  2016-04-22       Impact factor: 5.250

6.  Comparison of Steroid Modulation of Spontaneous Inhibitory Postsynaptic Currents in Cultured Hippocampal Neurons and Steady-State Single-Channel Currents from Heterologously Expressed α1β2γ2L GABA(A) Receptors.

Authors:  Sampurna Chakrabarti; Mingxing Qian; Kathiresan Krishnan; Douglas F Covey; Steven Mennerick; Gustav Akk
Journal:  Mol Pharmacol       Date:  2016-01-14       Impact factor: 4.436

7.  Structure-activity studies of non-steroid analogues structurally-related to neuroprotective estrogens.

Authors:  Mingxing Qian; Elizabeth B Engler-Chiurazzi; Sara E Lewis; Nigam P Rath; James W Simpkins; Douglas F Covey
Journal:  Org Biomol Chem       Date:  2016-10-18       Impact factor: 3.876

Review 8.  Synthetic neurosteroids on brain protection.

Authors:  Mariana Rey; Héctor Coirini
Journal:  Neural Regen Res       Date:  2015-01       Impact factor: 5.135

Review 9.  Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications.

Authors:  HuaLin Cai; Ting Cao; Xiang Zhou; Jeffrey K Yao
Journal:  Front Psychiatry       Date:  2018-03-08       Impact factor: 4.157

10.  Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond.

Authors:  Charles F Zorumski; Steven M Paul; Douglas F Covey; Steven Mennerick
Journal:  Neurobiol Stress       Date:  2019-09-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.